E. Ormsby

发表

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

Thomas Layloff, Vinod P. Shah, Kamal K. Midha, 1992 .

2012 white paper on recent issues in bioanalysis and alignment of multiple guidelines.

Sam H Haidar, Lauren F. Stevenson, Lauren F Stevenson, 2012, Bioanalysis.

Evidence that amikacin ototoxicity is related to total perilymph area under the concentration-time curve regardless of concentration

M. Hodgen, E. Ormsby, M. Downes, 1991, Antimicrobial Agents and Chemotherapy.

Delay in Hearing Loss Following Drug Administration

M. Hodgen, E. Ormsby, J. Salley, 1990 .

Incidence of amikacin ototoxicity: a sigmoid function of total drug exposure independent of plasma levels.

M. Hodgen, E. Ormsby, J. Salley, 1989, American journal of otolaryngology.

Logarithmic transformation in bioequivalence: application with two formulations of perphenazine.

K. Midha, J. Hubbard, G. Mckay, 1993, Journal of pharmaceutical sciences.

Short-term pathological and proliferative effects of butylated hydroxyanisole and other phenolic antioxidants in the forestomach of Fischer 344 rats.

E. Ormsby, E. Nera, F. Iverson, 1984, Toxicology.

Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients.

I. McGilveray, K. Gallicano, E. Ormsby, 1993, British Journal of Clinical Pharmacology.

Comparison of Fresh Feces with Lyophilized and Frozen Cultures of Feces as Inocula to Prevent Salmonella Infection in Chicks.

E. Ormsby, C. Rigby, H. Pivnick, 1982, Journal of food protection.

Metered-dose inhalers, I: Drug content and particle size distribution of beclomethasone dipropionate.

E. Ormsby, M. Lebelle, S. Graham, 1996, Journal of pharmaceutical and biomedical analysis.

Toxicodynamics and toxicokinetics of amikacin in the guinea pig cochlea

E. Ormsby, A. Beaubien, K. Karpiński, 1995, Hearing Research.

2011 White paper on recent issues in bioanalysis and regulatory findings from audits and inspections.

Stacy Ho, Eric Woolf, Binodh DeSilva, 2011, Bioanalysis.

Quasi-Likelihood Approach to Bioavailability and Bioequivalence Analysis

A. Desmond, R. Singh, C. Xie, 2008 .

Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report.

Lawrence X. Yu, V. Shah, J. Dressman, 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

In vitro assessment of cytotoxicity and biotransformation of propranolol in Cunninghamella echinulata.

D. L. Wilson, E. Ormsby, B. Foster, 1992, Xenobiotica; the fate of foreign compounds in biological systems.

Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop Summary Report

Lawrence X. Yu, J. Dressman, T. Hyslop, 2011, The AAPS Journal.

Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies

Thomas Layloff, Vinod P. Shah, Kamal K. Midha, 1992, Pharmaceutical Research.

2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMS.

Stacy Ho, Roger Hayes, Eric Woolf, 2013, Bioanalysis.

The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis.

Fabio Garofolo, Natasha Savoie, Steve Lowes, 2009, Bioanalysis.

2009 White Paper on recent issues in regulated bioanalysis from the 3rd Calibration and Validation Group Workshop.

D. Fast, B. Booth, F. Garofolo, 2010, Bioanalysis.

2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance.

Eric Woolf, Surendra Bansal, Mohammed Jemal, 2010, Bioanalysis.